The Phase-III, Covid-19 Covaxin trials will commence from 14th November at AMU’s Jawaharlal Nehru Medical College Hospital (JNMCH) aimed at evaluating the safety and efficacy of the Covid-19 vaccine study led in collaboration with ICMR and Bharat Biotech. JNMCH is the stand-alone site in Uttar Pradesh chosen for the trail by Indian Council for Medical Research (ICMR).
Registration of the subjects will start from 10th November in the Old OPD Block Hall of JNMCH from 9 am to 2 pm.
Prof Tariq Mansoor (Vice-Chancellor of AMU) said that JNMC has enhanced the preparations for the trails after a nod from the ICMR which has sanctioned scientific, technical and non-technical staff and financial grant for the same.